Anger management improves with age In women, study says
July 2 (UPI) -- Remember your sweet-hearted grandmother, who never seemed out of sorts no matter what nonsense landed in her lap?
That's a skill, and it improves during a person's lifespan, a new study says.
Women get better at managing their anger as they age, starting in middle-age, researchers reported Wednesday in the journal Menopause.
That doesn't mean they're less angry. Researchers found that as women got older, they were more prone to anger and their anger became more intense, results show.
But women also became less likely to express their anger or act with hostility, researchers found.
"These findings are consistent with research on emotion regulation efforts during aging, such that efforts to control anger increase along with experiences of anger," concluded the research team led by Nancy Fugate Woods of the University of Washington School of Nursing in Seattle.
For the study, researchers analyzed data from 271 women taking part in the Seattle Midlife Women's Health Study, a long-term research project that started in the early 1990s.
As part of the project, participants filled out a questionnaire related to their anger and hostility levels up to four or five times over the years.
Results showed that as women aged, they became more adept at managing anger even though they felt it more acutely.
Researchers said this might be because women feel more generativity - a sense of positively impacting the world by caring for others, particularly future generations - as they go through middle age and menopause.
"Implying greater emotional complexity among older adults, some of these changes may be seen in midlife and contribute to a sense of integration and maturity, supporting the development of generativity with aging," researchers wrote.
Women also might become more tactical with their anger, expressing it in ways that are more positive and constructive to improve relationships, researchers said. Women who use anger in a positive way tend to feel better empowerment and self-regard.
More research is needed on women's anger in the context of everyday life, to provide more information on emotion regulation and anger management strategies, researchers said.
"The mental health side of the menopause transition can have a significant effect on a woman's personal and professional life," Dr. Monica Christmas, associate medical director for The Menopause Society, said in a news release.
"It is well recognized that fluctuations in serum hormone concentrations during the postpartum period, as well as monthly fluctuations in reproductive-aged women corresponding with their menstrual cycles and during perimenopause, can result in severe mood swings associated with anger and hostility," continued Christmas, who was not involved in the study.
"Educating women about the possibility of mood changes during these vulnerable windows and actively managing symptoms can have a profound effect on overall quality of life and health," she said.
More information
The American Psychological Association has more on anger management.
Copyright © 2025 HealthDay. All rights reserved.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
UPI
11 hours ago
- UPI
Peptides: performance-boosting, anti-aging drugs or harmful snake oil?
Today over 100 peptide medications are approved, including semaglutide – better known as Ozempic and Wegovy. Photo by Haberdoedas Photography/ Pexels For a growing number of middle-aged men, aging no longer means surrendering to sagging skin, sore joints or slowing metabolism. Instead, it's becoming a science experiment. The new frontier? Injectable peptides -- experimental compounds that promise rapid recovery, fat loss and muscle gains with the ease of a twice-daily to weekly jab. Once confined to elite labs and obscure bodybuilding forums, these amino acid chains are now flooding wellness spaces, social media feeds and online marketplaces. Although they are marketed as "next-generation biohacks" and "research chemicals, "many peptides are not approved for human use and lack basic clinical testing. Still, their popularity is growing -- fueled by testimonials, influencer hype and the seductive promise of turning back time. But beneath the surface of glossy marketing and fitness fantasies lies a far more sobering truth: many of these substances operate in a medical gray zone, with unknown long-term risks, questionable manufacturing standards and, in some cases, life-threatening side-effects. Peptides aren't entirely new to medicine. The first peptide drug -- insulin -- was isolated in 1921 and became commercially available in 1923. Today, more than 100 peptide medications are approved, including semaglutide -- better known as Ozempic and Wegovy. But the compounds now circulating in fitness communities represent a very different category. They're experimental substances that have shown promise in animal studies but have never undergone proper human trials. The 'Wolverine stack' One such compound, first discovered in human gastric juice, that is attracting lots of attention is BPC-157. Early animal studies suggest it may help repair damaged tissue throughout the body. Researchers tested it on mice, rats, rabbits and dogs without finding serious side-effects. The compound appears to support healing of the tendons, teeth and digestive organs, including the stomach, intestines, liver and pancreas. Scientists don't yet fully understand how BPC-157 works, but animal studies suggest it triggers several biological processes essential for healing. The compound appears to help cells move to damaged areas and encourages the growth of new blood vessels, bringing nutrients and oxygen to tissues in need of repair. Another compound gaining attention is TB500. It is a synthetic version of thymosin beta-4, a naturally occurring protein fragment that plays an important role in repairing and regenerating damaged cells and tissues. It also helps protect cells from further harm by reducing inflammation and defending against microbes. The combination of BPC-157 and TB500 has earned the nickname "the Wolverine stack," named after the Marvel superhero famous for his rapid healing. Then there's IGF-1 LR3, a modified version of a natural protein (IGF-1) linked to muscle growth. This synthetic compound was shown to increase muscle mass by 2.5 times in animal studies, though it has never been studied in humans. The limited human research that does exist for these compounds offers inconclusive results. For example, a study showed that over 90% of patients experienced reduced knee pain after BPC-157 injections. However, the study had no control group and several methodological issues, so the results should be viewed with caution. Hidden dangers Even though the early results seem exciting, these experimental compounds can be dangerous. Making them involves special chemicals called coupling agents, which can trigger serious allergic reactions, including anaphylaxis -- a life-threatening condition. The health consequences extend well beyond allergic reactions. Long-term injection of performance-enhancing substances can lead to heart failure that can occur rapidly with little warning, as documented in recent medical case studies of young bodybuilders. Injection-related injuries pose another significant threat. "Compartment syndrome" can develop at injection sites in leg muscles, causing numbness, blood clots and muscle spasms that result in permanent loss of function. In severe cases, skin and underlying tissue can suffer necrosis (tissue death), requiring antibiotics or surgery to treat. More alarming still are reports of users contracting HIV, hepatitis B and C, and serious eye infections from contaminated injections. These compounds don't just target muscles -- they affect the entire body in ways scientists are only beginning to understand. Some interfere with natural insulin production, while others activate biological pathways that healthy cells use for growth and repair. The concern is that these same pathways are exploited by cancer cells. The VEGF pathway, which promotes blood vessel growth, is active in about half of all human cancers, including melanoma and ovarian cancer. Laboratory studies suggest that thymosin beta-4 may play a role in helping colorectal and pancreatic cancers spread. While there's no direct evidence linking compounds like BPC-157 or TB500 to cancer, researchers emphasize that the long-term effects remain unknown because these substances have never undergone proper human trials. The World Anti-Doping Agency has banned these compounds, noting they lack approval from any health regulatory authority and are intended only as research tools. A growing problem Yet, their use appears to be spreading rapidly. A 2014 study found that 8.2% of gym members used performance-enhancing drugs. By 2024, a comprehensive review suggested the figure could be as high as 29%. Perhaps most concerning: only 38% of users recognized the health risks involved. These experimental compounds represent a dangerous gamble with long-term health. Unlike approved drugs, they haven't undergone the rigorous testing required to understand their safety profile in humans. While they may promise enhanced performance and healing, they deliver it at a cost that users may not fully understand until it's too late. The appeal is understandable -- who wouldn't want faster healing and better muscle tone? But the reality is these substances remain experimental for good reason. Until proper human trials are conducted, users are essentially volunteering as test subjects in an uncontrolled experiment with their own bodies. Adam Taylor is a professor of anatomy at Lancaster University. This article is republished from The Conversation under a Creative Commons license. Read the original article. The views and opinions in this commentary are solely those of the author.
UPI
11 hours ago
- UPI
Artificial sweetener sucralose may disrupt cancer treatment
Aug. 4 (UPI) -- Findings from a study in mice suggest that using a common artificial sweetener, sucralose, could hamper certain immunotherapy treatments in cancer patients. However, for folks reluctant to give up the ubiquitous sweetener, the same team of scientists may have found a way around the problem: Giving mice a supplement that boosts levels of the natural amino acid arginine appeared to negate the effect. "It's easy to say, 'Stop drinking diet soda,' but when patients are being treated for cancer, they are already dealing with enough, so asking them to drastically alter their diet may not be realistic," said study lead author Abby Overacre, an assistant professor of immunology at the University of Pittsburgh. "We need to meet patients where they are. That's why it's so exciting that arginine supplementation could be a simple approach to counteract the negative effects of sucralose on immunotherapy," she said. Her team published its findings Wednesday in Cancer Discovery. Just how might sucralose disrupt cancer immunotherapies? These treatments include powerful "immune checkpoint inhibitor immunotherapies," such as anti-PD1. This treatment works by boosting the activity of key immune system cells called T cells. T cells need arginine to function effectively if they aim to kill cancer cells, the researchers explained. In the mouse experiments, mice bred to have cancers such as adenocarcinoma or melanoma experienced a shift in their gut microbiomes when sucralose was added to their diets. This led to a flourishing of certain gut bacteria that break down arginine, depleting levels of the amino acid. "When arginine levels were depleted due to sucralose-driven shifts in the microbiome, T cells couldn't function properly," Overacre explained in a university news release. "As a result, immunotherapy wasn't as effective in mice that were fed sucralose." Mice who'd been placed an an anti-PD1 immunotherapy but given sucralose ended up having larger tumors and poorer cancer survival versus those unexposed to sucralose, the team found. But there was a solution: When the researchers gave the mice the supplements arginine or citruline, the potency of immunotherapy returned to normal levels. Of course, experiments in mice don't always pan out in people. However, a follow-up study in cancer patients appeared to support findings observed in mice. The same research team tracked outcomes for 132 patients with either advanced melanomas or lung cancers who had received anti-PD1 immunotherapy alone or in combination with chemotherapy. "We found that sucralose impeded the effectiveness of immunotherapies across a range of cancer types, stages and treatment modalities," said study senior author Dr. Diwakar Davar. "These observations raise the possibility of designing prebiotics, such as targeted nutrient supplementation for patients who consume high levels of sucralose," said Davar, an associate professor of medicine at the university. He said a trial is planned to test the effectiveness of citrulline supplementation in reversing the detrimental effects of sucralose on cancer immunotherapy. As Davar noted, citrulline is thought to boost arginine levels more than giving arginine itself. More information Find out more about anti-PD1 therapies at the U.S. National Cancer Institute. Copyright © 2025 HealthDay. All rights reserved.
Yahoo
12 hours ago
- Yahoo
Is it perimenopause ... or something else? A new wearable is helping women demystify symptoms like hot flashes and brain fog.
Many women say they don't feel informed at all about this stage of life. Why is it suddenly harder to find the right word or remember the name of the restaurant you used to go to? When did sleeping through the night become such a rarity? And what's up with that shoulder pain that came out of nowhere? Welcome to perimenopause — the transition period that kicks off years before you officially reach menopause. While hot flashes and night sweats steal most of the spotlight, there are many subtler and seemingly random symptoms that can crop up (itchy ears, anyone?). It can leave women feeling blindsided and lost, like they're navigating an ever-shifting landscape without a compass or a map. A 2022 survey of nearly 950 perimenopausal women in the U.K. found that more than 60% said they didn't feel informed at all about this stage of life. Other than hot flashes, 'most of the women were entirely unaware of the wide array of symptoms and so did not connect them to the perimenopause,' according to the study authors. A more recent survey of nearly 4,500 American women revealed that more than 55% of those ages 30 to 35 had symptoms that could be classified as 'moderate' or 'severe' on the Menopause Rating Scale (MRS), a common questionnaire that measures the intensity of menopause symptoms. That increased to more than 64% in women ages 36 to 40. But the researchers behind the survey found that most women don't talk to a health care professional about their symptoms until they reach their mid-50s. Many just muscle through an uncomfortable array of symptoms. A lot of it comes down to the fact that almost no one is taught about perimenopause and menopause (and most doctors aren't adequately trained in it), so they may not know what signs to look out for and how to best manage symptoms. Technology is stepping in to fill the gap. The latest: a wearable device that's specifically designed to help women track perimenopause symptoms and figure things out sooner. It's called Peri by identifyHer, and it's a first-of-its-kind tool to help midlife women be better informed about this stage of life and their health. Here's what's behind this innovative technology, plus what menopause experts think. The problem: Figuring out whether you're in perimenopause is like playing a guessing game — but with your health. And managing symptoms can be difficult if you don't know where to start. By the numbers: A 2021 survey found that 44% of women were unaware of perimenopause until they started experiencing symptoms, while 46% were not expecting perimenopause when it started. A more recent survey by Ohio State Wexner Medical Center revealed that more than 60% of women believe they will reach menopause in their 40s. However, perimenopausal symptoms can start as early as your 30s, while the average age of menopause is 51, which can catch some women off guard. The solution: Peri by identifyHer is a wearable device with a corresponding app that's designed for women in perimenopause. It was a 2025 CES Innovation Awards Honoree and is relatively simple to use. The tool has an adhesive that sticks to your torso and collects data on everything from hot flashes and night sweats to sleep, anxiety and brain fog, sending that information to the app. It also gives personalized feedback on how to manage your specific symptoms. Chief executive officer and cofounder Heidi Davis tells Yahoo that the device was designed with the goal of supporting women. 'There's a critical lack of support and objective data when it comes to perimenopause — a stage that affects nearly every woman yet is still poorly understood,' she says. 'Beyond helping women in the moment, Peri aims to help close the gender data gap by gathering women-specific health data. Perimenopausal symptoms can be an early signal for future health outcomes, and understanding them better is key to keeping women healthier and more productive for longer.' Peri continuously monitors perimenopausal symptoms over time to analyze patterns and provide advice on next steps for women. 'These include tailored feedback on lifestyle around diet and exercise, feedback on hormone replacement therapy if applicable and tracking of symptoms across the cycle — helping women identify underlying causes of things like sleep disruption, e.g., is it night sweats? Anxiety?' Davis says. 'It also helps prompt more informed conversations with health care providers by offering a clear picture of what's going on.' Meaning, you can take the app's findings to your doctor to go over what you're experiencing in detail. Doctors who treat women in perimenopause and menopause say these details can be helpful. 'Digitalized health is one of the best ways to implement health care and to truly understand a patient's progression, recovery and journey through certain medical conditions,' women's health expert Dr. Jessica Shepherd, an ob-gyn in Dallas and author of the book Generation M: Living Well in Perimenopause and Menopause, tells Yahoo. 'The hormonal shifts seen in perimenopause and menopause are able to be tracked with a device such as this, which is valuable, especially since the journey of this transition is very hard to contextualize to a group of women.' Dr. Lauren Streicher, a clinical professor of obstetrics and gynecology at Northwestern University Feinberg School of Medicine, tells Yahoo that a device like this can help women identify symptoms they may not realize are from perimenopause and share them with their health care provider. 'Women are not aware of all of their hot flashes,' she says, pointing out that these can happen overnight when women are sleeping. 'There is value in knowing how many hot flashes you're actually having and whether whatever you're doing to try to make them go away is working,' Streicher says. That actually matters more than just knowing your health stats. 'There is a correlation between the severity of symptoms in perimenopause, such as hot flashes and night sweats, that can have a direct link to future health implications, such as heart disease, neurodegenerative diseases and overall quality of life,' Shepherd says. 'There is data that shows the increased severity of either hot flashes or night sweats was associated with a higher risk of cardiovascular disease.' While some experts say the wearable device is useful, Dr. Mary Jane Minkin, a clinical professor of obstetrics and gynecology and reproductive sciences at Yale School of Medicine and founder of Madame Ovary, says you don't need it to help you navigate perimenopause comfortably. 'As a general rule, things that are helpful for perimenopausal symptoms are also very good for medical health in general: getting lots of exercise (both aerobic and strength training) and eating a healthy diet — some varieties of a Mediterranean diet are good for most women,' Minkin tells Yahoo. 'Stopping smoking and avoiding excess alcohol — I discourage women from drinking more than one drink a day — are also good to minimize perimenopausal symptoms.' Minkin says it's also crucial to find a health care provider who understands perimenopause. (She recommends focusing on providers who are members of the Menopause Society and Menopause Society-certified practitioners.) Davis says she hopes her tool can help women make sense of what's happening to their bodies at this stage of life. 'Symptoms [of perimenopause] are often dismissed or misattributed, and women are left to manage on their own,' she says. 'There's a massive opportunity to bring clarity, support and personalization to this experience.' Preorders for Peri open in September 2025, and the first devices will ship in October.
